WA
AMPE

WealthTrust Axiom’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

WealthTrust Axiom’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed – – 261
2022
Q3 		$0 Hold
33
– – ﹤0.01% 257
2022
Q2 		$1K Hold
33
– – ﹤0.01% 251
2022
Q1 		$4K Hold
33
– – ﹤0.01% 270
2021
Q4 		$5K Hold
33
– – ﹤0.01% 269
2021
Q3 		$16K Hold
33
– – 0.01% 255
2021
Q2 		$16K Hold
33
– – 0.01% 266
2021
Q1 		$16K Hold
33
– – 0.01% 254
2020
Q4 		$15K Hold
33
– – 0.01% 239
2020
Q3 		$9K Hold
33
– – ﹤0.01% 207
2020
Q2 		$6K Hold
33
– – ﹤0.01% 206
2020
Q1 		$4K Hold
33
– – ﹤0.01% 197
2019
Q4 		$5K Hold
33
– – ﹤0.01% 233
2019
Q3 		$5K Hold
33
– – ﹤0.01% 239
2019
Q2 		$3K Hold
33
– – ﹤0.01% 239
2019
Q1 		$5K Hold
33
– – ﹤0.01% 235
2018
Q4 		$3K Hold
33
– – ﹤0.01% 216
2018
Q3 		$5K Hold
33
– – ﹤0.01% 232
2018
Q2 		$22K Hold
33
– – 0.01% 226
2018
Q1 		$34K Hold
33
– – 0.01% 222
2017
Q4 		$40K Hold
33
– – 0.01% 222
2017
Q3 		$6K Hold
33
– – ﹤0.01% 217
2017
Q2 		$5K Hold
33
– – ﹤0.01% 222
2017
Q1 		$8K Hold
33
– – ﹤0.01% 232
2016
Q4 		$9K Hold
33
– – ﹤0.01% 228
2016
Q3 		$7K Hold
33
– – ﹤0.01% 225
2016
Q2 		$12K Hold
33
– – ﹤0.01% 227
2016
Q1 		$22K Hold
33
– – 0.01% 217
2015
Q4 		$35K Hold
33
– – 0.01% 218
2015
Q3 		$28K Hold
33
– – 0.01% 216
2015
Q2 		$23K Hold
33
– – 0.01% 224
2015
Q1 		$75K Hold
33
– – 0.03% 221
2014
Q4 		$34K Hold
33
– – 0.01% 227
2014
Q3 		$35K Hold
33
– – 0.01% 223
2014
Q2 		$83K Hold
33
– – 0.03% 211
2014
Q1 		$63K Hold
33
– – 0.02% 201
2013
Q4 		$71K Hold
33
– – 0.03% 185
2013
Q3 		$75K Buy
+33
New +$63.8K 0.03% 175

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

WealthTrust Axiom's AMPE Position: Q4 2022 in Review

WealthTrust Axiom sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 33 shares.

WealthTrust Axiom first reported a position in AMPE in Q3 2013 and held it in 37 quarters. The position peaked at $83K in Q2 2014. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • WealthTrust Axiom reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • WealthTrust Axiom sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2022.
  • WealthTrust Axiom first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 37 quarters.
  • WealthTrust Axiom's Ampio Pharmaceuticals Inc. position peaked at $83K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on WealthTrust Axiom's 13F filing for Q4 2022, filed 31 Jan 2023.